Cancer is relentless. So are we. ARTBIO redefines cancer care by discovering and developing a new class of Alpha Radioligand Therapies (ARTs), powered by unique Pb-212 isotope technology and seamless supply. Our team works tirelessly to bring therapies that matter to patients who need them.
| Website | http://www.artbio.com |
| Revenue | $5.9 million |
| Employees | 76 (44 on RocketReach) |
| Address | B200, Suite 001, Cambridge, Massachusetts 02139, US |
| Industry | Biotechnology Research |
| Keywords | Clinical Stage Therapeutics, Cancer Treatment, Oncology, Radiotherapy, Nuclear Medicine, Pharmaceutical Development, Biotechnology, Drug Development, Clinical Trials, Cancer Research, Molecular Medicine, Therapeutic Radiopharmaceuticals, Patient Centric Care, Innovative Cancer Therapies, New Drug Applications |
| Competitors | Roche, Thermo Fisher Scientific, Merck Group, Agilent Technologies, Illumina, Lonza, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Sartorius +43 more (view full list) |
Looking for a particular ARTBIO employee's phone or email?
ARTBIO Questions
The ARTBIO annual revenue was $5.9 million in 2026.
Emanuele Ostuni is the CEO of ARTBIO.
44 people are employed at ARTBIO.
ARTBIO is based in Cambridge, Massachusetts.
Top ARTBIO Employees
-
Emanuele Ostuni
CEO at ARTBIO
Reinach, BL, CH35+ -
Margaret Yu
Chief Medical Officer at ARTBIO
Los Angeles, CA, US25+ -
Scott Tria
Vice President and Head of Discovery at ARTBIO
Boston, MA, US31 -
Nikki Hadas
Chief Legal Officer at ARTBIO
Boston, MA, US25+ -
Conrad Wüller
Vice President Operations at ARTBIO
Geneva, GE, CH31 -
Calvin Lee
Vice President Finance at ARTBIO
Zurich, Switzerland34 -
Jonathan Freeman
Chief Executive Officer at ARTBIO
Cambridge, MA, US5+3 -
Heng Li
Director of Early Discovery at ARTBIO
Cambridge, MA, US33
Related Companies
G2Crowd Trusted
300K+
Plugin Users
